DexCom Inc. (DXCM) Social Stream
DEXCOM INC (DXCM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering DXCM.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-03 | 18 | $750 | $438 | $572.764 | $128.93 | 344.24% |
2021-12-10 | 17 | $750 | $438 | $573.058 | $128.93 | 344.47% |
2022-01-07 | 17 | $750 | $438 | $581 | $128.93 | 350.63% |
2022-01-18 | 16 | $750 | $438 | $580.647 | $128.93 | 350.36% |
2022-01-25 | 16 | $750 | $438 | $569.176 | $128.93 | 341.46% |
2022-02-01 | 16 | $750 | $438 | $568.176 | $128.93 | 340.69% |
2022-02-11 | 17 | $750 | $438 | $566.333 | $128.93 | 339.26% |
2022-02-14 | 16 | $725 | $438 | $551.235 | $128.93 | 327.55% |
2022-03-14 | 17 | $725 | $438 | $548.388 | $128.93 | 325.34% |
2022-04-13 | 17 | $725 | $438 | $553.944 | $128.93 | 329.65% |
2022-04-29 | 16 | $725 | $488 | $566.058 | $128.93 | 339.04% |
2022-05-02 | 15 | $600 | $480 | $537.4 | $128.93 | 316.82% |
2022-05-23 | 15 | $600 | $480 | $536.625 | $128.93 | 316.21% |
2022-05-24 | 15 | $600 | $480 | $539.066 | $128.93 | 318.11% |
2022-05-31 | 14 | $600 | $480 | $539.066 | $128.93 | 318.11% |
2022-06-07 | 13 | $150 | $90.75 | $133.16 | $128.93 | 3.28% |
2022-06-13 | 13 | $150 | $37.5 | $125.125 | $128.93 | -2.95% |
2022-06-16 | 13 | $150 | $37.5 | $125.142 | $128.93 | -2.94% |
2022-06-17 | 13 | $150 | $37.5 | $124.357 | $128.93 | -3.55% |
2022-07-15 | 13 | $150 | $37.5 | $116.7 | $128.93 | -9.49% |
2022-09-17 | 14 | $145 | $83 | $104.187 | $128.93 | -19.19% |
2022-10-07 | 13 | $145 | $83 | $105.333 | $128.93 | -18.3% |
2022-10-11 | 14 | $145 | $85 | $108.466 | $128.93 | -15.87% |
2022-10-12 | 15 | $145 | $85 | $109.5 | $128.93 | -15.07% |
2022-10-27 | 15 | $145 | $85 | $109.117 | $128.93 | -15.37% |
2022-10-31 | 14 | $145 | $97 | $120.529 | $128.93 | -6.52% |
2022-11-21 | 15 | $145 | $97 | $120.529 | $128.93 | -6.52% |
2022-12-12 | 16 | $146 | $97 | $123.235 | $128.93 | -4.42% |
2022-12-15 | 16 | $150 | $97 | $124.411 | $128.93 | -3.51% |
2022-12-19 | 16 | $150 | $97 | $125 | $128.93 | -3.05% |
2023-01-13 | 15 | $150 | $97 | $124.625 | $128.93 | -3.34% |
2023-02-10 | 15 | $150 | $97 | $124.411 | $128.93 | -3.51% |
2023-02-13 | 15 | $150 | $97 | $125.47 | $128.93 | -2.68% |
2023-02-17 | 15 | $150 | $97 | $126.058 | $128.93 | -2.23% |
2023-03-03 | 15 | $150 | $97 | $126.647 | $128.93 | -1.77% |
2023-04-17 | 15 | $150 | $97 | $128.588 | $128.93 | -0.27% |
2023-04-28 | 16 | $150 | $97 | $128.588 | $128.93 | -0.27% |
2023-05-01 | 15 | $150 | $97 | $133.352 | $128.93 | 3.43% |
2023-06-26 | 16 | $150 | $97 | $133.352 | $128.93 | 3.43% |
2023-07-04 | 16 | $150 | $97 | $134.294 | $128.93 | 4.16% |
2023-07-11 | 16 | $150 | $97 | $134.529 | $128.93 | 4.34% |
2023-07-27 | 15 | $150 | $97 | $136.375 | $128.93 | 5.77% |
2023-07-31 | 16 | $160 | $121 | $147.937 | $128.93 | 14.74% |
2023-08-21 | 16 | $160 | $121 | $146.5 | $128.93 | 13.63% |
2023-09-06 | 17 | $160 | $121 | $146 | $128.93 | 13.24% |
2023-09-15 | 17 | $160 | $121 | $144.647 | $128.93 | 12.19% |
2023-10-02 | 17 | $160 | $98 | $140.647 | $128.93 | 9.09% |
2023-10-10 | 17 | $160 | $98 | $140.058 | $128.93 | 8.63% |
2023-10-16 | 18 | $160 | $98 | $138.388 | $128.93 | 7.34% |
2023-10-26 | 17 | $160 | $98 | $132.705 | $128.93 | 2.93% |
2023-10-30 | 18 | $155 | $101 | $128.777 | $128.93 | -0.12% |
2023-11-20 | 18 | $155 | $101 | $128.944 | $128.93 | 0.01% |
2023-11-24 | 19 | $155 | $101 | $128.473 | $128.93 | -0.35% |
2023-12-04 | 19 | $155 | $110 | $129.578 | $128.93 | 0.5% |
2023-12-15 | 19 | $155 | $110 | $129.684 | $128.93 | 0.58% |
2023-12-19 | 19 | $155 | $110 | $130.473 | $128.93 | 1.2% |
The Trend in the Analyst Price Target
DXCM's average price target has moved down $406.15 over the prior 19 months.
Over the past 49 weeks, DXCM's average upside potential has been 20.68%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-06-26 | 16 | 150 | 97 | 134.294 | 124.62 | 7.76% |
2023-07-10 | 16 | 150 | 97 | 134.529 | 130.62 | 2.99% |
2023-07-11 | 15 | 150 | 97 | 134.529 | 131.23 | 2.51% |
2023-07-11 | 16 | 150 | 97 | 134.529 | 131.23 | 2.51% |
2023-11-24 | 19 | 155 | 101 | 128.473 | 112.95 | 13.74% |
DXCM Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.21 | 17 | 0 | 2 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
Over the past 46 months, DXCM's average broker recommendation rating improved by 0.37.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DXCM as an investment opportunity.
- DXCM has a greater average analyst price target than 6541.96% of all US stocks.
- In the context of Healthcare stocks, DEXCOM INC's number of analysts covering the stock is higher than 6686.24% of them.
- To contextualize these metrics, consider that out of Medical Equipment stocks, DEXCOM INC's upside potential (average analyst target price relative to current price) is greater than 2744.38% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, DEXCOM INC's variance in analysts' estimates is lower than -2829.25% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to DEXCOM INC are RMD, BSX, and SYK.
View All Top Stocks by Price Target
Is DXCM a Buy, Hold or Sell? See the POWR Ratings now!